ClinicalTrials.gg
CompletedNCT02683551Updated Apr 9, 2024

Comparison of QoL for Sutureless Thyroidectomy

An observational study in Thyroidectomy and Quality of Life, sponsored by Istanbul University. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-09.

Sponsored by Istanbul University · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
193
Ages
18 Years and older
Sex
All
01

Study summary

Patients underwent thyroidectomy filled an computer or paper based QoL questionnaire before and after operation.

Read the detailed description

Patients who have consent to undergo to total thyroidectomy with sutureless technique (regardless of attending to study or not) for benign thyroid diseases in the institution are asked to participate to this study. Patients are informed that participating to this study will not alter their treatment method. Patients were operated either with Ligasure SmallJaw or Harmonic Focus according to result of label picked from bag. Same surgical team performed all operations and they did not know if the patient was participated in study or not.

Patients willing to participate in this study are being questioned for their quality of life (QoL) with a patient-reported outcome (PRO) questionnaire before surgery and 4 weeks after surgery. For assessment of quality of life Thy-PRO-39 questionnaire is being used. Responses of patients to QoL questionnaire is being recorded to a secure online database. After data completion answers of patients will be exported as anonymous to principal investigator for analysis. Effect of two energy based devices (EBD) on QOL will be compared.

02

Conditions studied

  • Thyroidectomy
  • Quality of Life
03

In context

Lead sponsor

Istanbul University is the lead sponsor of 507 studies on the registry; 80 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who has planned to undergo to sutureless thyroidectomy for benign conditions.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Sutureless thyroidectomy for benign conditions

Exclusion criteria

Exclusion Criteria:

  • Known neck malignity,
  • History of neck operation
  • Ligation use during surgery
  • Refusal of patient
  • Non-capable patient
  • Non-euthyroid patient
  • Pregnancy
  • Having rheumatic diseases
  • Having connective tissue diseases
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
193 participants (actual)
Patient registry
No

Groups and cohorts

  • Ligasure

    Patients underwent to Sutureless Thyroidectomy with Ligasure SmallJaw

    Procedure: Sutureless Thyroidectomy

  • Harmonic

    Patients underwent to Sutureless Thyroidectomy with Harmonic FOCUS

    Procedure: Sutureless Thyroidectomy

Interventions

  • ProcedureSutureless Thyroidectomy

    Thyroidectomy performed with energy based devices and no use of ligation. Used device is not altered for this study. Non of the personnel in the operating room including surgical team knows if the patient was enrolled or not in this study.

06

What researchers measure

Primary outcomes

  1. Overall alterations in quality of life according to Thy-PRO-39 questionnaire

    Time frame: 4 weeks

Secondary outcomes

  1. Alterations in social life according to Thy-PRO-39 questionnaire

    Time frame: 4 weeks

  2. Alterations in daily life according to Thy-PRO-39 questionnaire

    Time frame: 4 weeks

  3. Alterations in Tiredness according to Thy-PRO-39 questionnaire

    Time frame: 4 weeks

  4. Alterations in cognitive complaints according to Thy-PRO-39 questionnaire

    Time frame: 4 weeks

  5. Alterations in anxiety according to Thy-PRO-39 questionnaire

    Time frame: 4 weeks

  6. Alterations in depressivity according to Thy-PRO-39 questionnaire

    Time frame: 4 weeks

  7. Alterations in emotional susceptibility according to Thy-PRO-39 questionnaire

    Time frame: 4 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Watt T, Bjorner JB, Groenvold M, Cramon P, Winther KH, Hegedus L, Bonnema SJ, Rasmussen AK, Ware JE Jr, Feldt-Rasmussen U. Development of a Short Version of the Thyroid-Related Patient-Reported Outcome ThyPRO. Thyroid. 2015 Oct;25(10):1069-79. doi: 10.1089/thy.2015.0209. Epub 2015 Aug 26. PubMed 26214034 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2016, a primary completion of May 2016 and a completion of Jun 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 24, 2015
First posted
Feb 17, 2016
Start
Jan 2016
Primary completionActual
May 2016
CompletionActual
Jun 2016
Last update
Apr 9, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02683551
Responsible party
Akif Enes ARIKAN (MD, Istanbul University) — Principal investigator
First posted
Feb 17, 2016
Start date
Jan 2016
Primary completion
May 2016
Completion
Jun 2016
Last update
Apr 9, 2024

Study contacts

Ates OZYEGIN, Prof, MD
study director · Istanbul University, Cerrahpasa Medical Faculty

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion